CNS Depressants
Links shared publicly online about this topic
FDA Panel Looks at CNS Depressant for Fibromyalgia - QualityPoint Technologies
qualitypointtech.net — “BETHESDA, Md. (MedPage Today) -- A joint FDA advisory committee will meet here Friday to consider whether the narcolepsy drug sodium oxybate (Xyrem) should receive an additional indication to treat fibromyalgia.” View full resource at qualitypointtech.net
Most Recently Shared on August 19, 2010 at 11:21 pm By:
FDA Panel Looks at CNS Depressant for Fibromyalgia: BETHESDA, Md. (MedPage Today) -- A joint FDA advisory committe... http://bit.ly/9l81Vz
Medical News: FDA Panel Looks at CNS Depressant for Fibromyalgia - in Rheumatology, Fibromyalgia from MedPage Today
medpagetoday.com — “BETHESDA, Md. -- A joint FDA advisory committee will meet here Friday to consider whether the narcolepsy drug sodium oxybate (Xyrem) should receive an additional indication to treat fibromyalgia.” View full resource at medpagetoday.com
Most Recently Shared on August 19, 2010 at 10:58 pm By:
FDA Panel Looks at CNS Depressant for Fibromyalgia: BETHESDA, Md. (MedPage Today) -- A joint FDA advisory committe... http://bit.ly/cuYj9k
Neura.net: Perspectives on CNS Disease Management
neura.net — “Neura.net: Perspectives on CNS Disease Management” View full resource at neura.net
Most Recently Shared on December 31, 2009 at 2:51 am By:
Peruse & print out MS patient literature, incl. articles about depression, caregiving, vision problems, & drug dvlpmnt. http://bit.ly/64c9lU
Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental Health Congress
medicalnewstoday.com — “Cns response, inc. (otcbb: cnso) announced that the company will present top-line results from its multi-site clinical trial next week at the u.s. psychiatric and mental health congress. referen” View full resource at medicalnewstoday.com
Most Recently Shared on October 29, 2009 at 11:58 am By:
Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental .. http://bit.ly/1kyKGs
Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental Health Congress
medicalnewstoday.com — “CNS Response, Inc. (OTCBB: CNSO) announced that the company will present top-line results from its multi-site clinical trial next week at the U.S. Psychiatric and Mental Health Congress. Referen” View full resource at medicalnewstoday.com
Most Recently Shared on October 29, 2009 at 11:32 am By:
Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental .. http://bit.ly/11bXd
Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental Health Congress | Psydir News
news.psydir.com — “CNS Response, Inc. (OTCBB: CNSO) announced that the company will present top-line results from its multi-site clinical trial next week at the U.S. Psychiatric and Mental Health Congress.” View full resource at news.psydir.com
Most Recently Shared on October 30, 2009 at 5:27 am By:
Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental Heal... http://ow.ly/15YgVO
Chocolate: cause or cure for depression? | NutritionData.com Blog by Monica Reinagel, L.D.N., C.N.S.
blog.nutritiondata.com — “Curious findings on the relationship between chocolate and depression in this weeks Archives of Internal Medicine. Researchers found that those who reported eating the most chocolate were more likely to” View full resource at blog.nutritiondata.com
Most Recently Shared on April 28, 2010 at 3:04 pm By:
23rd Congress Of The European College Of Neuropsychopharmacology (ECNP), Pioneering CNS Research, Translating Neuroscience Into Clinical Progress
medicalnewstoday.com — “Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the tota” View full resource at medicalnewstoday.com
Most Recently Shared on August 27, 2010 at 2:00 pm By:
23rd Congress Of The European College Of Neuropsychopharmacology (ECNP), Pioneering CNS Research, Translating Neurosci... http://mnt.to/3HWH
Family Medicine Article | Depression
mdlinx.com — “Vilazodone: In Major Depressive Disorder” View full resource at mdlinx.com
Most Recently Shared on June 30, 2011 at 2:43 am By:
Vilazodone: In Major Depressive Disorder: CNS Drugs http://bit.ly/joSfqV #FamPractice
Neurology Medical News about Depression
mdlinx.com — “Steroids-Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders” View full resource at mdlinx.com
Most Recently Shared on May 26, 2010 at 9:14 am By:
Steroids-Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders: CNS Neuros... http://bit.ly/cBgasN #neurology #mdlinx
23rd ECNP Congress: Pioneering CNS Research -- Translating Neuroscience Into Clinical Progress - Health News - redOrbit
redorbit.com — “Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world.” View full resource at redorbit.com
Most Recently Shared on August 26, 2010 at 11:19 pm By:
23rd ECNP Congress: Pioneering CNS Research -- Translating Neuroscience Into Clinical Progress: Aug. 28-Sept. 1, 2... http://bit.ly/atS419
Psychiatry Medical News about Depression
mdlinx.com — “Deficits in Psychological Well-Being and Quality-of-Life in Minor Depression: Implications for DSM-V” View full resource at mdlinx.com
Most Recently Shared on July 5, 2010 at 2:30 pm By:
Deficits in Psychological Well-Being and Quality-of-Life in Minor Depression: Implications for DSM-V: CNS Neur... http://bit.ly/d9Lyss #PSY
Psychiatry Medical News about Depressive Disorder, Major
mdlinx.com — “Agomelatine in the Treatment of Major Depressive Disorder: Potential for Clinical Effectiveness” View full resource at mdlinx.com
Most Recently Shared on May 12, 2010 at 1:22 pm By:
Agomelatine in the Treatment of Major Depressive Disorder: Potential for Clinical Effectiveness: CNS Drugs http://bit.ly/cf6Kr8 #PSY
Rexahn Pharmaceuticals Submits Serdaxin Phase IIb Protocol To FDA For Major Depressive Disorder (MDD)
medicalnewstoday.com — “Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, announced that it has s” View full resource at medicalnewstoday.com
Most Recently Shared on September 9, 2010 at 2:00 pm By:
Rexahn Pharmaceuticals Submits Serdaxin Phase IIb Protocol To FDA For Major Depressive Disorder (MDD) http://mnt.to/3JtK #depression
Rexahn Pharmaceuticals Issues Additional Comments And Clarifications On Its Phase IIa Study Results Of Serdaxin In Major Depressive Disorder (MDD)
medicalnewstoday.com — “Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system (CNS) therapeutics, today offered addi” View full resource at medicalnewstoday.com
Most Recently Shared on April 16, 2010 at 7:35 am By:
Rexahn Pharmaceuticals Issues Additional Comments And Clarifications On Its Phase IIa Study Results Of Se.. http://mnt.to/f/3BjG #depression
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
-
Patricia Grace
Founder and CEO Aging with Grace, National Senior Care Examiner, Examiner.com Host, Aging with Grace,BlogTalkRadio
-
Neuranet News
Activity and info of relevance to neurodegenerative diseases of the CNS. Feed administrator: Expert Medical Education.
Advertisement

